Malaysia Launches NPRA GCP, GLP, BE & EC Inspection Dashboard

National Pharmaceutical Regulatory Agency (NPRA) announced the official launch of the GCP, GLP, BE and EC Inspection Dashboard on its website.

Purpose of the Dashboard

The dashboard was developed as part of NPRA’s ongoing efforts to strengthen regulatory oversight and enhance transparency.

This initiative aligns with the principles of the Global Benchmarking Tool (GBT).

Scope and Functionality

The dashboard serves as a centralized platform providing access to inspection-related information under the following areas:

• Good Clinical Practice (GCP)
• Good Laboratory Practice (GLP)
• Bioequivalence (BE) centre inspections
• Ethics Committee (EC) inspections

Available Information

Through the platform, external stakeholders can access:

• Annual reports related to inspections
• Key updates on inspection activities

Regulatory Impact

The publication of this dashboard reflects NPRA’s focus on:

• transparency
• accountability
• stakeholder engagement

It supports regulatory oversight of:

• clinical research
• bioequivalence studies
• ethics committees
• GLP facilities

Target Audience

The dashboard is intended for use by:

• clinical trial sponsors
• contract research organisations
• bioequivalence centres
• ethics committees
• GLP facilities
• researchers and other interested parties

NPRA encourages all relevant stakeholders to access the platform as a reference for inspection-related information.

The dashboard may be accessed via the following link:

NPRA GCP, GLP, BE and EC Inspection Dashboard

For more information:

Official Launch of the NPRA GCP, GLP, BE & EC Inspection Dashboard

Supporting Regulatory Processes

Access to structured inspection data and regulatory updates is essential for organizations involved in clinical research and laboratory compliance.

Baupharma’s Regulatory Affairs services support companies in preparing for inspections, maintaining compliance with GCP and GLP requirements, and managing regulatory interactions effectively:
https://www.baupharma.com/services-categories/regulatory-affairs/#Regulatory-affairs-services